Clinical Trial Update: A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer. [Phase 2]

View source ↗

Summary

Phase 2 study of capecitabine in combination with oxaliplatin (XELOX) for metastatic nasopharyngeal cancer has completed enrollment/status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Nasopharyngeal Cancer | Phase 2 | Status: COMPLETED